NOTCH1 and acute lymphoblastic leukemia: One patient sample responded drastically to NOTCH1 inhibitor (Fig. 2b, c), suggesting a mutation in the NOTCH pathway, which was subsequently confirmed to be a NOTCH1 mutation prevalent in T-ALL.